Skip to main content

Thermo Fisher Scientific Value Stock - Dividend - Research Selection

Thermo fisher scientific

ISIN: US8835561023 , WKN: 857209

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Thermo Fisher Scientific (NYSE:TMO) shareholders have earned a 17% CAGR over the last five years

2024-05-03
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...

Thermo Fisher launches CXCL10 test for kidney transplant patients

2024-05-03
Elevated urinary CXCL10 levels have been associated with inflammation and early kidney transplant rejection.

Thermo Fisher Scientific Launches New CXCL10 Testing Service

2024-05-03
WEST HILLS - For organ transplant recipients, life post-transplant involves a delicate balance between invasive monitoring and immunosuppression to reduce the risk of rejection, both of which may...

The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Disney, Southern Copper, Tractor Supply and Omnicom

2024-05-02
Thermo Fisher Scientific, Disney, Southern Copper, Tractor Supply and Omnicom are included in this Analyst Blog.

Top Research Reports for Thermo Fisher Scientific, Walt Disney & Southern Copper

2024-05-01
Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), The Walt Disney Company (DIS) and Southern Copper Corporation (SCCO).

Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink

2024-05-01
WALTHAM, Mass., May 01, 2024--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the "Buyer"), has extended the expiration time of the offering period of its previously announced tender offer (the "Offer") to acquire all of the outstanding common shares ("Shares") and all of the outstanding American Depositary Shares, each representing one Share ("ADSs" and, together with the Shares,

Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Conmed (CNMD) and BioMarin Pharmaceutical (BMRN)

2024-04-30
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Invest with Confidence: Intrinsic Value Unveiled of Thermo Fisher Scientific Inc

2024-04-30
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Thermo Fisher price target raised by $10 at HSBC, here's why

2024-04-30
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Thermo Fisher: Renewed Growth Yet To Materialize, But Already Priced In (Rating Downgrade)

2024-04-30
Thermo Fisher is expected to have near zero revenue and earnings growth in 2024. Find out why TMO stock is a Hold.